يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Arias Murillo, Yazmín Rocío"', وقت الاستعلام: 1.05s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المصدر: Biomedica; Vol. 36 (2016): Suplemento 2, Enfermedades virales; 187-193 ; Biomédica; Vol. 36 (2016): Suplemento 2, Enfermedades virales; 187-193 ; 2590-7379 ; 0120-4157

    وصف الملف: application/pdf; text/html

    العلاقة: https://revistabiomedica.org/index.php/biomedica/article/view/2938/3232Test; https://revistabiomedica.org/index.php/biomedica/article/view/2938/3259Test; Hansen SG, Powers CJ, Richards R, Ventura AB, Ford JC, Siess D, et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science. 2010;328:102-6. http://dx.doi.org/10.1126/science.1185350Test; Schnitzler MA, Lowell JA, Hardinger KL, Boxerman SB, Bailey TC, Brennan DC. The association of cyto-megalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis. Am J Transplant. 2003;3:445-51. http://dx.doi.org/10.1034/j.1600-6143.2003Test. 00069.x; Arthurs SK, Eid AJ, Pedersen RA, Kremers WK, Cosio FG, Patel R, et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis. 2008;46:840-6. http://dx.doi.org/10.1086/528718Test; Bataille S, Moal V, Gaudart J, Indreies M, Purgus R, Dussol B, et al. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression. Transpl Infect Dis. 2010;12:480-8. http://dx.doi.org/10.1111/j.1399-3062.2010.00533.xTest; Enders G, Daiminger A, Lindemann L, Knotek F, Bäder U, Exler S, et al. Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010. Med Microbiol Immunol. 2012;201: 303-9. http://dx.doi.org/10.1007/s00430-012-0232-7Test; Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalo-virus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20:202-13. http://dx.doi.org/10.1002/rmv.655Test; Lopo S, Vinagre E, Palminha P, Paixao MT, Nogueira P, Freitas MG. Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003. Euro Surveill. 2011;16:19896.; Vilibic-Cavlek T, Ljubin-Sternak S, Ban M, Kolaric B, Sviben M, Mlinaric-Galinovic G. Seroprevalence of TORCH infections in women of childbearing age in Croatia. J Matern Fetal Neonatal Med. 2011;24:280-3. http://dx.doi.org/10.3109/14767058.2010.485233Test.; Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. Seroprevalence of HHV-8, CMV and EBV among the general population in Ghana, West Africa. BMC Infect Dis. 2008;8:111. http://dx.doi.org/10.1186/1471-2334-8-111Test; Ministerio de Salud y Protección Social. Decreto 2493 de 2004. Por el cual se reglamentan parcialmente las Leyes 9ª de 1979 y 73 de 1988, en relación con los componentes anatómicos. Diario Oficial No.45631. Bogotá: Imprenta Nacional de Colombia; 2004.; Instituto Nacional de Salud. Documento técnico nacional. Comisión de Riñón. 6ª versión, 2014. Fecha de consulta: 10 de junio de 2015. Disponible en: http://www.ins.gov.co/lineas-de-accion/Red-Nacional-Laboratorios/Marco%20Legal%20documentos%20tcnicos%20y%20estadistica%20red%20d/COMISION%20RI%C3%91ON%20Version%20No%206%20-2014.pdfTest.; Instituto Nacional de Salud. Informe red donación y trasplantes 2010. Fecha de consulta: mayo 10 del 2015. Disponible en: http://www.ins.gov.co/lineas-de-accion/Red-Nacional-Laboratorios/Estadsticas/Informe%20FinalRed%20D%20Tx%20-%202010.pdfTest.; Instituto Nacional de Salud. Informe anual, Red de Donación y Trasplantes. Volumen 1, Bogotá, 2011. Fecha de consulta: 10 de mayo de 2015. Disponible en: http://www.ins.gov.co/lineas-de-accion/Red-Nacional-Laboratorios/Estadsticas/Informe%20Red%20Donacion%20y%20Trasplantes%20%20Vol%201%202011.pdfTest.; Instituto Nacional de Salud. Informe anual, Red de Donación y Trasplantes. Volumen 2, Bogotá, 2012. Fecha de consulta: 10 de mayo de 2015. Disponible en: http://www.ins.gov.co/lineas-de-accion/Red-Nacional-Laboratorios/Estadsticas/Informe_Red%20donacion%20y%20trasplantes%20Vol2_2012.pdfTest.; Instituto Nacional de Salud. Informe anual, Red de Donación y Trasplantes. Volumen 3, Bogotá, 2013. Fecha de consulta: 10 de mayo de 2015. Disponible en: http://www.ins.gov.co/lineas-de-accion/Red-Nacional-Laboratorios/Estadsticas/INFORME%20ANUAL%202013%20RED%20DE%20DONACION%20Y%20TRASPLANTES.%20Vol%2003.pdfTest.; Beltrán M, Ayala M, Jara J. Frecuencia de grupos sanguíneos y factor Rh en donantes de sangre, Colombia, 1996. Biomédica. 1999;19:39-44. http://dx.doi.org/10.7705/biomedica.v19i1.1006Test; Korcáková L, Kaslík J, Svobodová J, Kaslíková J, Bláha J, Sedlácková E, et al. CMV infection in patients with chronic renal failure and in those following transplantation. Czech Med. 1988;11:131-6.; Sibrowski W, Kühnl P, Kalmar G, Albert S, Böhm BO, Doerr HW. Cytomegalovirus diagnosis in blood donors and risk patients. Beitr Infusionsther. 1990;26:37-9.; Trkulic M, Jovanovic D, Ostojic G, Kovacevic Z, Taseski J. Cytomegalovirus infection in patients with kidney diseases. Vojnosanit Pregl. 2000;57:63-7.; Vilibic T, Kolaric B, Ljubin S, Kos M, Kaic B, Mlinaric G. Prevalence and dynamics of cytomegalovirus infection among patients undergoing chronic hemodialysis. Indian J Nephrol. 2015;25:95-98. http://dx.doi.org/10.4103/0971-4065.139488Test; Betjes MG, Litjens NH, Zietse R. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant. 2007;22:3298-303. http://dx.doi.org/10.1093/ndt/gfm348Test; Kao TW, Hsu WA, Chen HS, Chen WY. A two year follow-up study of common virus infections in hemodialysis patients in Taiwan. Artif Organs. 2002;26:879-83. http://dxTest. doi.org/10.1046/j.1525-1594.2002.07053.x; Jha V. Post-transplant infections: An ounce of prevention. Indian J Nephrol. 2010;20:171-8. http://dx.doi.org/10Test. 4103/0971-4065.73431; Cordero E, Casasola C, Ecarma R, Danguilan R. Cytomegalovirus disease in kidney transplant recipients: Incidence, clinical profile, and risk factors. Transplant Proc. 2012;44:694-700. http://dx.doi.org/10.1016/j.transproceedTest. 2011.11.053; Cavdar C, Celtik A, Saglam F, Sifil A, Atila K, Celik A, et al. Cytomegalovirus disease in renal transplant recipients: A single-center experience. Ren Fail. 2008;30:503-6. http://dx.doi.org/10.1080/08860220802064705Test; Enan KA, El-Hussein AM, El Eragi A, Elkhider IM. Sero-reactivity to human cytomegalovirus in a cohort of Sudanese renal transplant patients. Khartoum Med J. 2009;2:197-9.; Sagedal S, Nordal KP, Hartmann A, Degre M, Holter E, Foss A, et al. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation. 2000;70:1166-74.; Correa MR, Correa M, Arbeláez M, Builes M, Ossa J. Prevalencia de infección por citomegalovirus en receptores y donantes de trasplante renal en Medellín para 1988-1989. Acta Médica Colombiana. 1990;15:175-9.; Diaz J, Henao J, Rodelo J, García A, Arbeláez M, Jaimes F. Incidence and risk factors for cytomegalovirus disease in a Colombian cohort of kidney transplant recipients. Transplant Proc. 2014;46:160-6. http://dx.doi.org/10.1016/j.transproceed.2013.07.070Test; Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96:333-60. http://dx.doi.org/10.1097/TP.0b013e31829df29dTest; Cortés JA, Yomayusa N, Arias YR, Arroyave IH, Cataño JC, García P, et al. Consenso colombiano para la estratificación, diagnóstico, tratamiento y prevención de la infección por citomegalovirus en pacientes adultos con trasplante renal. Infectio. 2016. http://dx.doi.org/10.1016/j.infect.2015.10.005Test; https://revistabiomedica.org/index.php/biomedica/article/view/2938Test

  4. 4
  5. 5